, O W. Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation. J. Biol. Chem. 2001, 276(29):26906-15. Postprint available at: http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Originally published at: J. Biol. Chem. 2001, 276(29):26906-15. Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation Abstract Dopamine (DA) is a key hormone in mammalian sodium homeostasis. DA induces natriuresis via acute inhibition of the renal proximal tubule apical membrane Na(+)/H(+) exchanger NHE3. We examined the mechanism by which DA inhibits NHE3 in a renal cell line. DA acutely decreases surface NHE3 antigen in dose-and time-dependent fashion without altering total cellular NHE3. Although DA(1) receptor agonist alone decreases surface NHE3, simultaneous DA(2) agonist synergistically enhances the effect of DA(1). Decreased surface NHE3 antigen, caused by stimulation of NHE3 endocytosis, is dependent on intact functioning of the GTPase dynamin and involves increased binding of NHE3 to the adaptor protein AP2. DA-stimulated NHE3 endocytosis can be blocked by pharmacologic or genetic protein kinase A inhibition or by mutation of two protein kinase A target serines (Ser-560 and Ser-613) on NHE3. We conclude that one mechanism by which DA induces natriuresis is via protein kinase A-mediated phosphorylation of proximal tubule NHE3 leading to endocytosis of NHE3 via clathrin-coated vesicles. Abstract Dopamine (DA) is a key hormone in mammalian Na homeostasis. DA induces natriuresis via acute inhibition of the renal proximal tubule apical membrane Na/H exchanger NHE3. We examined the mechanism by which DA inhibits NHE3 in a renal cell line. DA acutely decreases surface NHE3 antigen in dose and timedependent fashion without altering total cellular NHE3. While DA 1 receptor agonist alone decreases surface NHE3, simultaneous DA 2 agonist synergistically enhanced the effect of DA 1 . Decreased surface NHE3 antigen is due to stimulation of NHE3 endocytosis, is dependent on intact function of the GTPase dynamin, and involves increased binding of NHE3 to the adaptor protein AP2. The DA-stimulated NHE3 endocytosis can be blocked by pharmacologic or genetic PKA inhibition, or by mutation of two PKA target serines (S560 and S613) on NHE3. We conclude that one mechanism by which DA induces natriuresis is via PKA-mediated phosphorylation of proximal tubule NHE3 leading to endocytosis of NHE3 via clathrin-coated vesicles. Extracellular fluid volume and to a certain extent blood pressure in mammals is determined by the balance between Na intake and renal Na excretion (1, 2). As regulator of Na excretion, the intra-renal autocrine-paracrine dopamine (DA) system assumes far greater importance than circulating endocrine or neurogenic dopamine (3-6). DA is produced in the proximal tubule via decarboxylation of its precursor Ldihydroxy-phenylalanine derived from the plasma and glomerular filtrate (7-9) and is then secreted into the tubular lumen where it exerts its effects on multiple nephron segments that cumulates in inhibition of tubular Na absorption and natriuresis. Renal DA synthesis and excretion is increased by increased dietary salt and an intravenous saline load (10-13) and blockade of DA synthesis or DA receptor significantly blunts the natriuretic response (14-18). Quantitatively, the most significant inhibition of Na transport occurs in the proximal tubule. DA inhibits proximal tubule Na absorption partially by hemodynamic alterations (19-22) but the major effect is directly on the tubule epithelium (23-26) via inhibition of two principal Na transporters: The apical membrane Na/H exchanger NHE3 (27-33) and the basolateral Na-K-ATPase (34-38). These effects are mediated by the DA receptor where five molecular isoforms (DR 1 -like receptors: DR 1 and DR 5, and DR 2 -like receptors: DR 2 , DR 3 , DR 4 ) have been identified to date; all five isoforms are known to be present in the renal tubular epithelium (39-43).
Extracellular fluid volume and to a certain extent blood pressure in mammals is determined by the balance between Na intake and renal Na excretion (1, 2) . As regulator of Na excretion, the intra-renal autocrine-paracrine dopamine (DA) system assumes far greater importance than circulating endocrine or neurogenic dopamine (3) (4) (5) (6) . DA is produced in the proximal tubule via decarboxylation of its precursor Ldihydroxy-phenylalanine derived from the plasma and glomerular filtrate (7) (8) (9) and is then secreted into the tubular lumen where it exerts its effects on multiple nephron segments that cumulates in inhibition of tubular Na absorption and natriuresis. Renal DA synthesis and excretion is increased by increased dietary salt and an intravenous saline load (10) (11) (12) (13) and blockade of DA synthesis or DA receptor significantly blunts the natriuretic response (14) (15) (16) (17) (18) . Quantitatively, the most significant inhibition of Na transport occurs in the proximal tubule. DA inhibits proximal tubule Na absorption partially by hemodynamic alterations (19) (20) (21) (22) but the major effect is directly on the tubule epithelium (23) (24) (25) (26) via inhibition of two principal Na transporters: The apical membrane Na/H exchanger NHE3 (27) (28) (29) (30) (31) (32) (33) and the basolateral Na-K-ATPase (34) (35) (36) (37) (38) . These effects are mediated by the DA receptor where five molecular isoforms (DR 1 -like receptors: DR 1 and DR 5, and DR 2 -like receptors: DR 2 , DR 3 , DR 4 ) have been identified to date; all five isoforms are known to be present in the renal tubular epithelium (39) (40) (41) (42) (43) .
Previous studies in isolated apical membrane vesicles have shown that DA inhibits proximal tubule apical membrane Na/H exchange activity mainly via DR 1 -like receptors (25-28, 30, 31, 33) through both PKA-dependent and PKA independent mechanisms (27, 31) . The Na/H exchanger on the apical membrane of the renal at Hauptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 8, 2010 www.jbc.org Downloaded from proximal tubule is encoded by NHE3 (44) (45) (46) ; one of the 7 members of the NHE gene family (47) . We have shown in OK cells that the DA 1 -like and DA 2 -like receptors have synergistic actions on NHE3 activity and that inhibition of NHE3 activity by DA is accompanied by complex changes in NHE3 phosphorylation and dephosphorylation (33) . However, the mechanisms by which DA acutely reduces NHE3 activity has not been examined. Redistribution of NHE3 transporters has been shown to mediate regulation of NHE3 activity in intact kidney (48) (49) (50) (51) (52) (53) (54) , in cultured renal epithelial cells (55, 56) and transfected fibroblasts (57-64). In addition, although NHE phosphorylation has been associated with changes in NHE3 activity (52, (65) (66) (67) (68) ) and phosphorylation appears to be functionally important for regulation of NHE3 activity by pharmacologic activators of protein kinases in transfected fibroblasts (65) (66) (67) , the physiologic significance of NHE3 phosphorylation is still undetermined. In this manuscript, we characterize one mechanism by which DA acutely inhibits NHE3; the internalization of NHE3 secondary to PKA-mediated NHE3 phosphorylation and NHE3 endocytosis via clathrin-coated vesicles.
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Methods
Cell culture, agonists, transfection and plasmid constructs. OK (opossum kidney) cells were maintained in high glucose Dulbecco's modified Eagle's medium, supplemented with Na pyruvate (1 mM), fetal bovine serum (10%, v:v), penicillin (100 units/ml), and streptomycin (100 :g/ml) and were rendered quiescent postconfluence by serum removal for 48 hours prior to experimentation. Transient transfections were performed with lipofectamine (Gibco, Gaithersburg MD). Measurement of surface NHE3 antigen, NHE3 endocytosis and exocytosis.
These assays were performed as previously described (56) . To measure surface NHE3, OK cells were surface labeled with biotin using a modification of the method of Gottardi after addition of agonists (56, 69) 
Results
DA decreases surface NHE3 protein. In the OK cell, DA decreases NHE3
protein in a time and dose-dependent fashion (Fig 1 and Fig 2) . Typical experiments are shown in Figs 1A and 2A and the summarized data is shown in Fig 1B and 2B .
The dose-dependence (Fig 1) of decrease in surface NHE3 (half maximal decrease at 10 -5 M and maximal decrease of 70% at 10 -4 M measured after 30 mins DA) is similar to that of DA-induced inhibition of NHE3 activity previously described (33) .
The time-dependence (Fig 2) of decrease in surface NHE3 however is discrepant with changes in NHE3 activity. While decrease in NHE3 activity is evident after 5 mins of DA (33), decrease in surface NHE3 is not detectable until after 30 mins.
There was no change in total cellular NHE3 within the experimental period ( Fig 1A) .
Identical results were obtained from studying native OKNHE3 protein or with OK cells transiently expressing NHE3/c-myc/6H (not shown).
In addition to the biochemical biotin assay, we also examined the effect of DA on NHE3 by imaging live cells. OK cells were transiently transfected with NHE3/eGFP and fluorescent microscopy on live transfected cells showed NHE3 to be a typical brush border protein with the characteristic punctate staining (Fig 3) .
Addition of DA caused a time-dependent decrease in surface NHE3 with appearance of a characteristic intracellular staining pattern (Fig 3) . Within the 2 hrs of fluorescent microscopic examination, no significant decrease in total cellular NHE3 was appreciated. This is compatible with the biochemical data presented above.
Addition of vehicle served as time control where no change in NHE3 distribution was seen (Fig 3) . while DA 2 alone was ineffective. The combination of DA 1 and DA 2 resulted in greater reduction of surface NHE3 than DA 1 alone. (Fig 4 A and B) . To further confirm these results, we used subtype-specific inhibitors to try to block the effect of DA on surface NHE3 (Fig 4C and D) . DA 1 blockade abolished most of the DAinduced decrease in surface NHE3 while DA 2 blockade had minimal effect. These findings are similar to the previously reported synergistic effect observed with the inhibition of NHE3 activity by DA 1 and DA 2 agonists (33).
DA stimulates NHE3 endocytosis via a dynamin-dependent clathrin-coated vesicle (CCV) pathway. NHE3 has been visualized in both the plasma membrane and in intracellular compartments in both native kidney tissue and culture cells (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) . The decrease in surface NHE3 in response to DA can be due to decreased exocytotic insertion or increased endocytotic retrieval. We quantified endocytotic rate biochemically with the MesNa-protection assay. Fig 5A &B shows that DA stimulated NHE3 endocytosis by 58%. When cells were kept at 4 o C to arrest trafficking, a small amount of MesNa-protected NHE3 was visible. This likely reflects incomplete cleavage of the NHS-biotin rather than endocytosis at 4 o C (Fig 5A) . This usually represents <10% of the signal. The GTPase dynamin is required for both clathrin and caveolin-mediated endocytosis (72, 73) . We next co-transfected the GTP bindingdefective dominant-negative dynamin I (dyn K44A ) along with c-myc tagged NHE3
into OK cells and studied the effect of DA on surface NHE3 protein (Fig 6A) . Since the read-out in this assay is with the anti-c-myc antisera which does not react with the native NHE3, only transfected cells were selectively studied. While cells transfected with wild type dynamin (dyn WT ) showed normal down-regulation of surface NHE3 by DA, cells transfected with dyn K44A failed to respond to DA (Fig 6A   & B) . A key component of the clathrin-coated vesicle endocytotic pathway is family of adaptor proteins (AP's) (73, 74) . We next examined the association of NHE3 with the adaptor protein AP2 by co-immunoprecipitation. Fig 7A shows that DA increased the amount of NHE3 bound to total cellular AP2. In fact, the association of NHE3 to AP2 is barely detectable without DA. In sum, our data indicate that DA shifts NHE3
from the plasma membrane to endocytic vesicles via a dynamin and AP2-dependent process.
DA-stimulated NHE3 endocytosis is dependent on NHE3 phosphorylation by PKA. To examine the role of PKA in DA-induced NHE3 endocytosis, PKA was inhibited either pharmacologically or genetically. In the presence of 10 -6 M H89, DA failed to decrease surface NHE3 (Fig 8) . As a second approach to ensure specific inhibition of PKA only, a dominant negative PKA regulatory subunit (RII mut ) was used to constitutively sequester all catalytic PKA subunits. RII mut binds stoichiometrically to the catalytic subunit but is devoid of both cAMP binding sites and hence does not release its pseudo substrate inhibition even in high ambient cAMP concentrations (66, 75) . In the background of RII mut , DA was unable to decrease surface NHE3 (Fig 8B) . These data indicate that intact PKA is necessary for DA to decrease surface NHE3. Note that in these experiments, we pulsed the cells with 5 mM 8Br-cAMP for 5 mins 16 hrs prior to exposure to DA or vehicle to Previous studies have mapped target serines (Ser552 and Ser605) on the cytoplasmic domain of rat NHE3 as functionally significant PKA substrates (65, 66) .
These serines are situated in highly conserved regions of NHE3 (Fig 9) . To examine the role of NHE3 phosphorylation in mediating NHE3 endocytosis, we eliminated To examine at which step does the serine mutations arrest endocytosis, we repeated the co-immunoprecipitation studies with AP2 using NHE3 S560A/ S613A . As shown in Figure 7B , the two serine mutations virtually abolished AP2 binding to NHE3. These studies support the model that NHE3 phosphorylation by PKA is necessary for its endocytotic retrieval.
Discussion
In addition to its role in maintaining Na homeostasis under normal conditions (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) , defects in the renal paracrine/autocrine DA axis as been demonstrated and postulated to contribute to certain forms of polygenic hypertension in both rodents (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) and humans (87) (88) (89) (90) (91) (92) . In the proximal tubule where 50-60% of NaCl and water are reabsorbed, DA inhibits the basolateral membrane Na + -K + -ATPase (34-38) which is primary driving force for transepithelial Na + absorption. In addition, DA also inhibits two apical Na + -coupled transporters, the Na + -coupled inorganic phosphate transporter (92-96) and the Na + /H + exchanger NHE3 (27) (28) (29) (30) (31) (32) (33) . In addition to transcellular Na + flux, inhibition of NHE3 also reduces the driving force for paracellular NaCl transport (97) . In concert, these mechanisms potently inhibit proximal tubule NaCl reabsorption.
NHE3 is regulated acutely by a variety of hormones (98-99). The acute
response of NHE3 to DA follows a biphasic response similar to that of parathyroid hormone previously described in rat kidney (52) and in OK cells (56) . Dyn K44A is expected to block all dynamin-dependent processes (102) . The net effect of dyn K44A in the absence of DA was higher levels of surface NHE3 protein (Fig 6A &   B) . Adaptin is believed to be the mediator that directs and initiate the assembly of the clathrin triskeleton and coated pit in the vicinity of the protein targeted to be retrieved www.jbc.org
Downloaded from alone appears to be sufficient to incur an effect while DA 2 alone is not. However, simultaneous DA 1 and DA 2 receptors activation produces a synergistic effect. This pattern is identical to that described for decreases in NHE3 activity (33) . The signaling pathways mediating NHE3 inhibition by DA is still controversial. The contribution of the DA 1 -Gas-adenylyl cyclase-protein kinase A axis is the only undisputed pathway (27, 31) although non-PKA cascades are most certainly involved (31, 33, 115) . In this manuscript, we focused only on the PKA pathway.
There is a difference in PKA-dependence between the acute inhibition of NHE3 activity and acute decrease in NHE3 surface antigen. While there appears to be a PKA-independent component of acute inhibition of NHE3 activity by DA, the DA- 
